Publication

An ‘indefensible’ decision: not vaccinating pregnant and lactating women in an Ebola outbreak

The rVSV-ZEBOV vaccine is currently the only Ebola vaccine that has successfully completed efficacy trials and is being used in response efforts. This vaccine would not likely be viewed as appropriate for use in pregnant women outside the context of an Ebola outbreak. But during a high-incidence Ebola outbreak, the catastrophic maternal and fetal mortality rates change the calculus, with the potential benefits of offering the vaccine to pregnant contacts clearly outweighing the potential harms.  Read the full article…